Showing results (41-50 of 59) with videos related to
Sort By:
Pageof 6
International Journal of Molecular Sciences|December 24, 2021
Distal Lung Microenvironment Triggers Release of Mediators Recognized as Potential Systemic Biomarkers for Idiopathic Pulmonary FibrosisDimitrios Kalafatis, Anna Löfdahl, Per Näsman, et al.European Journal of Clinical Investigation|January 3, 2013
Risk prediction in stable angina pectorisThomas Kahan, Lennart Forslund, Claes Held, et al.International Journal of Stroke : Official Journal of the International Stroke Society|January 20, 2025
Fluoxetine and fractures after stroke: An individual patient data meta-analysis of three large randomized controlled trials of fluoxetine for stroke recoveryGillian Mead, Catriona Graham, Erik Lundström, et al.Cardiovascular Diabetology|August 11, 2023
Empagliflozin improves insulin sensitivity in patients with recent acute coronary syndrome and newly detected dysglycaemia : Experiences from the randomized, controlled SOCOGAMI trialElena Fortin, Magnus Lundin, Linda Mellbin, et al.International Journal of Stroke : Official Journal of the International Stroke Society|March 18, 2024
Individual patient data meta-analysis of the effects of fluoxetine on functional outcomes after acute strokeGillian Mead, Catriona Graham, Erik Lundström, et al.Diabetes Care|December 6, 2023
High Mannose Correlates With Surrogate Indexes of Insulin Resistance and Is Associated With an Increased Risk of Cardiovascular Events Independently of Glycemic Status and Traditional Risk FactorsElena Fortin, Beatrice Campi, Ele Ferrannini, et al.Cardiovascular Diabetology|July 8, 2022
Mannose-binding lectin does not explain the dismal prognosis after an acute coronary event in dysglycaemic patients. A report from the GAMI cohortSara Meziani, Giulia Ferrannini, Mette Bjerre, et al.Trials|November 26, 2020
Update to the FOCUS, AFFINITY and EFFECTS trials studying the effect(s) of fluoxetine in patients with a recent stroke: statistical analysis plan for the trials and for the individual patient data meta-analysisGillian Elizabeth Mead, Catriona Graham, Laurent Billot, et al.Scandinavian Cardiovascular Journal : SCJ|August 17, 2022
Long-term prognosis after a first myocardial infarction: eight years follow up of the case-control study PAROKRANKGiulia Ferrannini, Mariam Almosawi, Kåre Buhlin, et al.Diabetes Research and Clinical Practice|November 6, 2022
SOdium-glucose CO-transporter inhibition in patients with newly detected Glucose Abnormalities and a recent Myocardial Infarction (SOCOGAMI)Magnus Lundin, Giulia Ferrannini, Linda Mellbin, et al.Pageof 6